Detection of drug-induced disease.
作者信息
Lawson D H
出版信息
Br J Clin Pharmacol. 1979 Jul;8(1):84-5. doi: 10.1111/j.1365-2125.1979.tb05914.x.
Abstract
摘要
相似文献
1
Detection of drug-induced disease.药物诱发疾病的检测
Br J Clin Pharmacol. 1979 Jul;8(1):84-5. doi: 10.1111/j.1365-2125.1979.tb05914.x.
2
Detection of drug-induced disease.药物诱发疾病的检测
Br J Clin Pharmacol. 1979 Jul;8(1):83-4. doi: 10.1111/j.1365-2125.1979.tb05913.x.
3
Detection of drug-induced disease.药物性疾病的检测
Br J Clin Pharmacol. 1979 Jan;7(1):13-8. doi: 10.1111/j.1365-2125.1979.tb00890.x.
4
Evaluation of spontaneous reports of adverse reactions to drugs.药物不良反应自发报告的评估
Br Med J. 1972 Sep 23;3(5829):746-9. doi: 10.1136/bmj.3.5829.746.
5
Detection and evaluation of adverse drug reactions.
JAMA. 1972 May 15;220(7):1011.
6
Adverse effects of drugs on the liver and their detection by laboratory tests.药物对肝脏的不良反应及其通过实验室检查的检测
Med Lett Drugs Ther. 1969 Mar 7;11(5):17-8.
7
How study of geographic epidemiology of disease can help in detection of adverse drug reactions.疾病地理流行病学研究如何有助于发现药物不良反应。
Clin Pharmacol Ther. 1976 May;19(5 Pt 2):679-82. doi: 10.1002/cpt1976195part2679.
8
HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.HLA相关的药物超敏反应与药物不良反应的预测
Pharmacogenomics. 2017 Oct;18(15):1441-1457. doi: 10.2217/pgs-2017-0090. Epub 2017 Oct 11.
9
Detection of adverse drug reactions: evaluation of an automatic data processing applied in oncology performed in the French Diagnosis Related Groups database.药物不良反应的检测：对法国诊断相关组数据库中肿瘤学应用的自动数据处理的评估。
Fundam Clin Pharmacol. 2018 Apr;32(2):227-233. doi: 10.1111/fcp.12333. Epub 2017 Nov 27.
10
Innovations in Medication Safety: Services and Technologies to Enhance the Understanding and Prevention of Adverse Drug Reactions.药物安全创新：增进对药物不良反应的认识与预防的服务和技术
Pharmacotherapy. 2018 Aug;38(8):782-784. doi: 10.1002/phar.2154. Epub 2018 Jul 22.
本文引用的文献
1
Unwanted effects of drugs.药物的不良反应
Br Med Bull. 1971 Jan;27(1):25-31. doi: 10.1093/oxfordjournals.bmb.a070809.
2
Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance.临床生物统计学。28. 药物监测的生物统计学问题。
Clin Pharmacol Ther. 1974 Jul;16(1):110-23. doi: 10.1002/cpt1974161part1110.
3
Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program.住院内科患者中普萘洛尔的不良反应：来自波士顿合作药物监测项目的报告。
Am Heart J. 1973 Oct;86(4):478-84. doi: 10.1016/0002-8703(73)90139-7.
4
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.β-肾上腺素能受体阻断药物的不良反应：来自波士顿药物监测协作计划的报告。
Drugs. 1974;7(1):118-29. doi: 10.2165/00003495-197407010-00008.
5
Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.静脉注射利多卡因的临床应用与毒性。波士顿药物监测协作计划的一份报告。
Am Heart J. 1976 Aug;92(2):168-73. doi: 10.1016/s0002-8703(76)80252-9.
6
Clinical toxicity of reserpine in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program.
Am J Med Sci. 1976 May-Jun;271(3):269-76. doi: 10.1097/00000441-197605000-00002.
7
Adverse reactions to practolol in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program.
Eur J Clin Pharmacol. 1977 Nov 14;12(3):167-70. doi: 10.1007/BF00609854.
8
Detection of drug-induced disease.药物诱发疾病的检测
Br J Clin Pharmacol. 1979 Jul;8(1):83-4. doi: 10.1111/j.1365-2125.1979.tb05913.x.
9
Detection of drug-induced disease.药物性疾病的检测
Br J Clin Pharmacol. 1979 Jan;7(1):13-8. doi: 10.1111/j.1365-2125.1979.tb00890.x.
Zotero 插件